Physician profile
Greg M Blakely
NPI 1962442723
$1,076.80
in general payments reported to CMS, 2019-2025
17 companies · $64.26 in 2025
The $64.26 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $543 · 2022: $250 · 2023: $147 · 2024: $72.33 · 2025: $64.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventric Diagnostics, INC. | $407.73 | 2021 | |
| Daiichi Sankyo INC. | $199.36 | 2021-2024 | Injectafer |
| Novo Nordisk INC | $69.29 | 2021-2024 | Rybelsus, Ozempic |
| Pfizer INC. | $55.81 | 2022-2025 | |
| Glaxosmithkline, LLC. | $54.38 | 2022-2024 | Arexvy, Shingrix |
| Boston Scientific Corporation | $46.52 | 2022-2025 | Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $39.21 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $36.27 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $33.24 | 2023 | Prehevbrio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.45 | 2022 | |
| Abbott Laboratories | $21.66 | 2022 | |
| Sumitomo Pharma America, INC. | $15.42 | 2023 | Gemtesa |
| Abbvie INC. | $14.26 | 2023 | Ubrelvy |
| Amgen INC. | $14.09 | 2021 | |
| Insightec,INC | $14.07 | 2025 | Exablate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $13.30 | 2021 | |
| Hologic Sales and Service, LLC | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Blakely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.